To assess the efficacy evaluation of buckwheat husk extract on cardiovascular disease risk factors
This is a double-blind and randomized study. Subjects are informed to consume the samples every day for 2 months. The clinical diagnosis item of cardiovascular disease is evaluated by the doctor.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
60
consume 1 sachet per day for 2 months
consume 1 sachet per day for 2 months
National Taiwan University Hospital
Taipei, Taiwan
RECRUITINGChange from baseline in blood pressure (systolic blood pressure, diastolic blood pressure)
Blood pressure will be measured at the beginning, 4-week, and 8-week time points.
Time frame: Days 1, 28, and 56
Change from baseline in Body Mass Index (BMI)
Body Mass Index (kg/m\^2) will be measured at the beginning, 4-week, and 8-week time points. P.S. weight in kilograms, height in meters
Time frame: Days 1, 28, and 56
Change from baseline in waist-hip ratio
Waist-hip ratio will be measured at the beginning, 4-week, and 8-week time points.
Time frame: Days 1, 28, and 56
Change from baseline in blood lipid (total-Cholesterol, triglyceride, HDL-C, LDL-C)
Blood lipid will be measured at the beginning, 4-week, and 8-week time points.
Time frame: Days 1, 28, and 56
Change from baseline in blood cardiovascular disease risk biomarker (hs-CRP, NO, Trimethylamine-N-oxide)
Blood cardiovascular disease risk biomarker will be measured at the beginning, 4-week, and 8-week time points.
Time frame: Days 1, 28, and 56
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.